By ETF Desk
The Manipal Health IPO has been open for subscription since March 21, 2022, and is expected to close on March 25, 2022. The IPO has been priced at ₹541-578 per equity share, with a total issue size of ₹4,350 crores. This makes it one of the largest IPOs in the healthcare sector in recent years.
The Manipal Health IPO has been seen as a good opportunity for investors to invest in the healthcare sector, which is expected to grow significantly in the coming years. The company has a strong presence in the healthcare sector, with a network of hospitals and clinics across the country. The IPO is expected to help the company expand its operations and improve its financials.
The Manipal Health IPO has received a mixed response from investors, with some analysts recommending a 'subscribe' rating and others advising investors to 'avoid' the IPO. The IPO has been priced at a premium, which may deter some investors from investing in it. However, the company's strong fundamentals and growth prospects make it an attractive investment opportunity for long-term investors.
Source: Google News – Manipal.